Showing results (111-120 of 133) with videos related to
Sort By:
Pageof 14
BMJ Neurology Open|November 10, 2022
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL StudyMarios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, et al.Scientific Reports|September 26, 2025
Leveraging multi-modal foundation model image encoders to enhance brain MRI-based headache classificationFazle Rafsani, Devam Sheth, Yiming Che, et al.The Journal of Headache and Pain|December 19, 2021
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort studyFabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.Neurology and Therapy|June 20, 2025
From Headache to Heart Health: Investigating the Migraine-Cardiovascular Disease ConnectionClaudio Tana, Dilara Onan, Roberta Messina, et al.Nature Reviews. Disease Primers|March 26, 2021
Tension-type headacheSait Ashina, Dimos D Mitsikostas, Mi Ji Lee, et al.Journal of Neurology|March 22, 2015
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutationsMaria A Rocca, Stefania Bianchi-Marzoli, Roberta Messina, et al.Scientific Reports|September 7, 2017
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patientsEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.International Journal of Cardiology. Heart & Vasculature|September 9, 2020
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularizationEnrico Ammirati, Francesco Moroni, Marco Magnoni, et al.Cephalalgia : an International Journal of Headache|May 28, 2025
Longitudinal analysis of pain-induced brain activations in post-traumatic headacheDohyun Ku, Lingchao Mao, Simona Nikolova, et al.Journal of Neurology|August 7, 2023
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.Pageof 14